Overlooked Biomarker May Predict Cancer Immunotherapy Response Overlooked Biomarker May Predict Cancer Immunotherapy Response

Dr David Kerr on data showing that tumors with extensive aneuploidy may not benefit as much from immune checkpoint blockade.Medscape Oncology
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news